Ubiquinol-10 Protects Human Low Density Lipoprotein More Efficiently Against Lipid Peroxidation Than Does Alpha-tocopherol

Overview

Journal Proc Natl Acad Sci U S A

Specialty Science

Date 1991 Mar 1

PMID 2000375

Citations 124

Authors

R Stocker

V. W. Bowry

B Frei

Affiliations

Soon will be listed here.

Abstract

The temporal disappearance of natural antioxidants associated with human low density lipoprotein (LDL) in relation to the appearance of various classes of lipid hydroperoxides was investigated under three types of oxidizing conditions. Freshly isolated LDL from plasma of healthy subjects was free of detectable amounts of lipid hydroperoxides as measured by HPLC postcolumn chemiluminescence detection. Exposure of such LDL to a mild, constant flux of aqueous peroxyl radicals led to rapid and complete oxidation of ubiquinol-10, followed by slower partial depletion of lycopene, beta-carotene, and alpha-tocopherol. After an initial lag period of complete inhibition of detectable lipid peroxidation, formation of hydroperoxides of cholesterol esters, triglycerides, and phospholipids was observed. The onset of detectable lipid peroxidation corresponded closely with the completion of ubiquinol-10 consumption. However, small amounts of ascorbate, present as a contaminant in the LDL preparation, rather than ubiquinol-10 itself were responsible for the initial lag period. Thus, complete consumption of ubiquinol-10 was preceded by that of ascorbate, and exposure of ascorbate-free LDL to aqueous peroxyl radicals resulted in immediate formation of detectable amounts of lipid hydroperoxides. The rate of radical-mediated formation of lipid hydroperoxides in ascorbate-free LDL was low as long as ubiquinol-10 was present, but increased rapidly after its consumption, even though more than 80% and 95% of endogenous carotenoids and alpha-tocopherol, respectively, were still present. Qualitatively similar results were obtained when peroxyl radicals were generated within LDL or when the lipoprotein was exposed to oxidants produced by activated human polymorphonuclear leukocytes. LDL oxidation was reduced significantly by supplementing the lipoprotein preparation with physiological amounts of either ascorbate or ubiquinol-10. Our data show that ubiquinol-10 is much more efficient in inhibiting LDL oxidation than either lycopene, beta-carotene, or alpha-tocopherol.

Citing Articles

Beneficial Antioxidant Effects of Coenzyme Q10 in In Vitro and In Vivo Models of CDKL5 Deficiency Disorder.

Loi M, Valenti F, Medici G, Mottolese N, Candini G, Bove A Int J Mol Sci. 2025; 26(5).

PMID: 40076840 PMC: 11900000. DOI: 10.3390/ijms26052204.

The Role of Natural Low Molecular Weight Dicarbonyls in Atherogenesis and Diabetogenesis.

Lankin V, Tikhaze A, Sharapov M, Konovalova G Rev Cardiovasc Med. 2024; 25(8):295.

PMID: 39228481 PMC: 11367011. DOI: 10.31083/j.rcm2508295.

Understanding coenzyme Q.

Wang Y, Lilienfeldt N, Hekimi S Physiol Rev. 2024; 104(4):1533-1610.

PMID: 38722242 PMC: 11495197. DOI: 10.1152/physrev.00040.2023.

Effects of coenzyme Q10 supplementation on oxidative stress biomarkers following reperfusion in STEMI patients undergoing primary percutaneous coronary intervention.

Yazdi A, Shirmohammadi K, Parvaneh E, Entezari-Maleki T, Hosseini S, Ranjbar A J Cardiovasc Thorac Res. 2024; 15(4):250-261.

PMID: 38357568 PMC: 10862029. DOI: 10.34172/jcvtr.2023.31817.

New Insights on the Uptake and Trafficking of Coenzyme Q.

Guile M, Jain A, Anderson K, Clarke C Antioxidants (Basel). 2023; 12(7).

PMID: 37507930 PMC: 10376127. DOI: 10.3390/antiox12071391.

References

GEY K, Puska P . Plasma vitamins E and A inversely correlated to mortality from ischemic heart disease in cross-cultural epidemiology. Ann N Y Acad Sci. 1989; 570:268-82. DOI: 10.1111/j.1749-6632.1989.tb14926.x. View

Rajavashisth T, Andalibi A, Territo M, Berliner J, Navab M, Fogelman A . Induction of endothelial cell expression of granulocyte and macrophage colony-stimulating factors by modified low-density lipoproteins. Nature. 1990; 344(6263):254-7. DOI: 10.1038/344254a0. View

Cross C, Forte T, Stocker R, Louie S, Yamamoto Y, Ames B . Oxidative stress and abnormal cholesterol metabolism in patients with adult respiratory distress syndrome. J Lab Clin Med. 1990; 115(4):396-404. View

Sato K, Niki E, Shimasaki H . Free radical-mediated chain oxidation of low density lipoprotein and its synergistic inhibition by vitamin E and vitamin C. Arch Biochem Biophys. 1990; 279(2):402-5. DOI: 10.1016/0003-9861(90)90508-v. View

Babiy A, Gebicki J, Sullivan D . Vitamin E content and low density lipoprotein oxidizability induced by free radicals. Atherosclerosis. 1990; 81(3):175-82. DOI: 10.1016/0021-9150(90)90064-p. View

Frei B, Kim M, Ames B . Ubiquinol-10 is an effective lipid-soluble antioxidant at physiological concentrations. Proc Natl Acad Sci U S A. 1990; 87(12):4879-83. PMC: 54222. DOI: 10.1073/pnas.87.12.4879. View

Beyer R . The participation of coenzyme Q in free radical production and antioxidation. Free Radic Biol Med. 1990; 8(6):545-65. DOI: 10.1016/0891-5849(90)90154-b. View

Cushing S, Berliner J, Valente A, Territo M, Navab M, Parhami F . Minimally modified low density lipoprotein induces monocyte chemotactic protein 1 in human endothelial cells and smooth muscle cells. Proc Natl Acad Sci U S A. 1990; 87(13):5134-8. PMC: 54276. DOI: 10.1073/pnas.87.13.5134. View

Kagan V, Serbinova E, Koynova G, Kitanova S, Tyurin V, Stoytchev T . Antioxidant action of ubiquinol homologues with different isoprenoid chain length in biomembranes. Free Radic Biol Med. 1990; 9(2):117-26. DOI: 10.1016/0891-5849(90)90114-x. View

10.

Steinbrecher U, Zhang H, Lougheed M . Role of oxidatively modified LDL in atherosclerosis. Free Radic Biol Med. 1990; 9(2):155-68. DOI: 10.1016/0891-5849(90)90119-4. View

11.

Yamamoto Y, Frei B, Ames B . Assay of lipid hydroperoxides using high-performance liquid chromatography with isoluminal chemiluminescence detection. Methods Enzymol. 1990; 186:371-80. DOI: 10.1016/0076-6879(90)86130-n. View

12.

Folkers K, Langsjoen P, Willis R, Richardson P, Xia L, Ye C . Lovastatin decreases coenzyme Q levels in humans. Proc Natl Acad Sci U S A. 1990; 87(22):8931-4. PMC: 55074. DOI: 10.1073/pnas.87.22.8931. View

13.

Esterbauer H, Jurgens G, Quehenberger O, Koller E . Autoxidation of human low density lipoprotein: loss of polyunsaturated fatty acids and vitamin E and generation of aldehydes. J Lipid Res. 1987; 28(5):495-509. View

14.

Grootveld M, Halliwell B . Measurement of allantoin and uric acid in human body fluids. A potential index of free-radical reactions in vivo?. Biochem J. 1987; 243(3):803-8. PMC: 1147928. DOI: 10.1042/bj2430803. View

15.

Cornell B, A Keniry M, Post A, ROBERTSON R, Weir L, Westerman P . Location and activity of ubiquinone 10 and ubiquinone analogues in model and biological membranes. Biochemistry. 1987; 26(24):7702-7. DOI: 10.1021/bi00398a025. View

16.

Frei B, Stocker R, Ames B . Antioxidant defenses and lipid peroxidation in human blood plasma. Proc Natl Acad Sci U S A. 1988; 85(24):9748-52. PMC: 282858. DOI: 10.1073/pnas.85.24.9748. View

17.

Steinberg D, Parthasarathy S, Carew T, Khoo J, Witztum J . Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity. N Engl J Med. 1989; 320(14):915-24. DOI: 10.1056/NEJM198904063201407. View

18.

Frei B, Yamamoto Y, Niclas D, Ames B . Evaluation of an isoluminol chemiluminescence assay for the detection of hydroperoxides in human blood plasma. Anal Biochem. 1988; 175(1):120-30. DOI: 10.1016/0003-2697(88)90369-7. View

19.

Frei B, ENGLAND L, Ames B . Ascorbate is an outstanding antioxidant in human blood plasma. Proc Natl Acad Sci U S A. 1989; 86(16):6377-81. PMC: 297842. DOI: 10.1073/pnas.86.16.6377. View

20.

Mellors A, Tappel A . The inhibition of mitochondrial peroxidation by ubiquinone and ubiquinol. J Biol Chem. 1966; 241(19):4353-6. View